[Pharmacokinetic and clinical studies on cefodizime in gynecologic field]. 1989

S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
Department of Obstetrics and Gynecology, Nagoya City University Medical School.

Pharmacokinetic and clinical studies on a new cephalosporin antibiotic, cefodizime (THR-221, CDZM), were performed and the results obtained are summarized as follows: 1. At about 84 minutes after a bolus injection of 1 g dose of CDZM, the drug was transferred well into tissues of internal genital organs and remained there at therapeutic levels for 285 minutes. The drug was also transferred quickly and sufficiently into exudate from pelvic dead space and its levels were still kept at high levels at 6 hours after administration. 2. CDZM was given to 8 women affected with gynecologic infections. The outcome of CDZM therapies showed that the drug was effective in all 8 of patients (100%) clinically and bacteriologically. 3. Notable adverse effects or abnormal laboratory test results were not observed except for 2 patients with transient and slight elevation of transaminase levels. Based on these results, it may be concluded that CDZM is a highly effective and a very safe antibiotic for the treatment on infectious diseases in gynecologic field.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D005836 Genitalia, Female The female reproductive organs. The external organs include the VULVA; BARTHOLIN'S GLANDS; and CLITORIS. The internal organs include the VAGINA; UTERUS; OVARY; and FALLOPIAN TUBES. Accessory Sex Organs, Female,Sex Organs, Accessory, Female,Genital Organs, Female,Genitals, Female,Reproductive System, Female,Female Genital,Female Genital Organ,Female Genital Organs,Female Genitalia,Female Genitals,Female Reproductive System,Female Reproductive Systems,Genital Organ, Female,Genital, Female,Reproductive Systems, Female
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000292 Pelvic Inflammatory Disease A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility. Adnexitis,Inflammatory Disease, Pelvic,Inflammatory Pelvic Disease,Pelvic Disease, Inflammatory,Disease, Inflammatory Pelvic,Disease, Pelvic Inflammatory,Diseases, Inflammatory Pelvic,Diseases, Pelvic Inflammatory,Inflammatory Diseases, Pelvic,Inflammatory Pelvic Diseases,Pelvic Diseases, Inflammatory,Pelvic Inflammatory Diseases
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
May 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
October 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
October 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
October 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
January 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
October 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
June 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
October 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
June 1989, The Japanese journal of antibiotics,
S Hanada, and T Kinbara, and K Aoki, and Y Yasui, and K Ikuta, and M Manzai, and K Mizuno, and Y Yagami, and H Sakaida, and Y Okumura
June 1989, The Japanese journal of antibiotics,
Copied contents to your clipboard!